Synthon B.V. engages in the development, production, and sale of medicines. The company offers products for various therapeutic areas, including hypercholesteremia, prostatic hyperplasia, depression, insomnia, schizophrenia, insomnia, hypertension, hypertension/BPH, depression, incontinence, virus infections, hypertension, heart failure, anti-inflammatory, neutralizing narcosis or overdose, prostate cancer, nausea after chemotherapy, and anaesthetic. Synthon B.V. also engages in chemical and pharmaceutical research. The company is based in Nijmegen, the Netherlands. Synthon B.V. operates as a subsidiary of Synthon Holding B.V.
| 
